Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
<b><i>Background:</i></b> Anthracyclines such as doxorubicin remain a primary treatment for hematological malignancies and breast cancers. However, cardiotoxicity induced by anthracyclines, possibly leading to heart failure, severely limits their application. The pathological mechanisms of anthracyc...
Bewaard in:
| Hoofdauteurs: | , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI AG
2023-01-01
|
| Reeks: | Antioxidants |
| Onderwerpen: | |
| Online toegang: | https://www.mdpi.com/2076-3921/12/2/320 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|